Related Experiment Video
Updated: Aug 7, 2026

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
Corticospinal conduction in RFC1-related disease: a transcranial magnetic stimulation study
Vicente Gajate-García1,2, María Fenollar-Cortés3, Fernando Alonso-Frech4
1Neuromuscular Diseases Unit, Department of Neurology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Calle Profesor Martín Lagos S/N, 28040, Madrid, Spain.
Background:
Biallelic intronic expansions in RFC1 cause cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS), which may present with hyperreflexia despite the coexistence of severe sensory neuropathy. The mechanism of this apparent corticospinal involvement remains unclear.
Methods:
We assessed corticospinal tract integrity by transcranial magnetic stimulation (TMS) in 18 patients with genetically confirmed RFC1-related disease. Resting motor threshold (RMT), central motor conduction time (CMCT), and motor evoked potential/compound muscle action potential (MEP/CMAP) amplitude ratios were recorded bilaterally from the abductor pollicis brevis and abductor hallucis muscles. Clinical phenotype, neuroimaging, peripheral neurophysiology, and medication exposure were reviewed.
Results:
Among the 18 patients, 5 (28%) showed clinical hyperreflexia, 10 had full CANVAS, 4 had complex neuropathy phenotypes, and 4 had isolated sensory neuropathy. RMT, CMCT, and MEP/CMAP ratios did not differ significantly between patients with and without hyperreflexia. Neuroimaging did not reveal a structural central nervous system cause in the majority of cases.
Conclusions:
Conventional TMS measures were within expected ranges and did not differ significantly according to hyperreflexia status. Hyperreflexia may occur in RFC1-related disease without detectable abnormalities in standard TMS metrics, although subtle corticospinal dysfunction cannot be excluded, particularly given the small sample size and the potential confounding effect of medication exposure.
More Related Videos
09:52Measuring and Manipulating Functionally Specific Neural Pathways in the Human Motor System with Transcranial Magnetic Stimulation
Published on: February 23, 2020
07:20Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024